Transgene

About Transgene SA

Transgene SA is a biotechnology company specializing in the design and development of therapeutic vaccines and oncolytic viruses for the treatment of cancer. Its clinical-stage immunotherapies target solid tumors such as lung, liver, head and neck, and colorectal cancers. Transgene also develops individualized therapeutic vaccines and multi-functional oncolytic viruses, with products in clinical trials for ovarian, HPV-positive, gastrointestinal, and other cancers. The company collaborates with major pharmaceutical partners and is headquartered in Illkirch-Graffenstaden, France.